Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16111 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16151 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16134 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-145 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 |
filingDate |
2018-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2020-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-102091281-B1 |
titleOfInvention |
Recombinant Influenza A virus H5N6 strain and Vaccine Composition for Highly Pathogenic Influenza A virus comprising the same |
abstract |
The present invention provides a vaccine composition for a recombinant influenza A virus H5N6 strain, a method for preparing the same, and an influenza A virus H5 serotype comprising the same. The vaccine composition is a vaccine with high antigenicity that maintains a high titer (2 7 ) up to 24 weeks, and provides the advantage of sufficiently protecting against viral infection by inoculation twice a year. |
priorityDate |
2018-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |